查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928280

生物來源Isododecane市場依原料類型、純度等級、應用、最終用戶和銷售管道－全球預測，2026-2032年

Bio-based Isododecane Market by Feedstock Type, Purity Grade, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年生物基異Isododecane市值為 1.7529 億美元，預計到 2026 年將成長至 2.1072 億美元，年複合成長率為 22.38%，到 2032 年將達到 7.2104 億美元。

關鍵市場統計數據
基準年 2025 1.7529億美元
預計年份：2026年 2.1072億美元
預測年份 2032 7.2104億美元
複合年成長率 (%) 22.38%

策略性實施方案，將生物基異Isododecane的物理化學優勢與配方優先順序、供應考量和監管考慮因素結合。

生物基異Isododecane作為一種用途廣泛、氣味低、快乾的碳氫化合物替代品，已在配方驅動型產業中廣受歡迎。隨著配方化學家和採購團隊尋求更優質的原料供應和永續性，生物基異Isododecane因其與敏感化妝品基質、吸入產品溶劑系統、潤滑劑基底和工業清潔配方的相容性而日益受到重視。其理化性質使其在對揮發性控制、膚感和溶劑純度要求極高的領域極具吸引力。

原料創新、認證要求和純化技術突破所驅動的變革性產業趨勢正在重塑生物基異Isododecane的應用路徑。

受永續性需求、發酵和催化製程的成熟以及原料供應變化等因素的影響，生物基異Isododecane的市場環境正在經歷結構性變革。可再生原料加工技術的創新正逐步改善雜質譜和可重複性，從而促進其在敏感應用領域的更廣泛應用。同時，買家越來越重視透明度和第三方認證，以支持其永續性聲明，這正在推動供應商選擇標準和合約條款的調整。

對2025年美國關稅調整對籌資策略、供應鏈結構和海關風險管理實務的影響進行全面分析

2025年的關稅環境為美國跨境供應鏈增添了新的複雜性，影響了採購決策和合約風險分配。關稅調整影響了到岸成本的計算，迫使採購團隊重新評估其供應商分佈、運輸策略和庫存管理政策。為此，一些買家轉向區域採購以最大限度地降低跨境關稅波動風險，而另一些買家則重新談判供應契約，以納入關稅分攤條款和彈性價格設定機制。

詳細的細分分析揭示了應用特定要求、純度差異、最終用戶優先事項、分銷管道趨勢和原料選擇如何決定認證和採購。

細分市場分析揭示了不同應用、純度等級、最終用戶、銷售管道和原料類型所帶來的獨特需求促進因素和合格路徑。該材料的價值提案在不同應用領域差異顯著：在化妝品領域，它可用作粉底、唇膏和保濕霜配方中的感官增強劑，這些產品對膚感和速乾性要求較高；在工業溶劑領域，其速乾、低殘留的溶劑特性適用於清潔劑和塗料；在潤滑劑領域，它可用作生物潤滑劑和特殊金屬加工液的生物基基礎材料，這些產品對熱穩定性和成膜性能要求較高；在製藥領域，它可用作吸入劑或外用溶劑，這些產品對溶劑純度和與活性成分的相容性要求較高。

區域趨勢和生產佈局影響美洲、歐洲、中東和非洲以及亞太地區的供應韌性、認證重點和物流最佳化。

生物基異Isododecane的地理趨勢取決於區域原料供應、法規結構和製造地。在美洲，由於地理位置接近性玉米和醣類原料產地，有利於本地生產和縮短供應鏈，而可追溯性和本土採購是買家優先考慮的因素。同時，在歐洲、中東和非洲地區，監管審查和永續性報告要求促使企業更加重視認證採購和生命週期透明度，製造商通常會投資於先進的提純技術，以滿足化妝品和藥品行業的嚴格標準。

關鍵競爭考察和能力洞察，重點在於闡述技術差異化、材料整合和附加價值服務如何決定供應商定位和客戶選擇。

生物基異Isododecane領域的競爭趨勢主要集中在技術差異化、原料整合、垂直整合和附加價值服務。領先的生產商通常將原料採購夥伴關係關係與下游提純能力和完善的品管系統相結合，以滿足高純度應用的需求。新參與企業和特種化學品製造商則往往透過提供靈活的合約規模、為配方師提供快速的中試支援以及基於第三方檢驗的新型原料特性來展開競爭。

為確保供應韌性、提升純度能力以及使商業模式與永續性和監管要求相符，提出切實可行的策略建議。

產業領導者應優先採取一系列切實可行的措施，將不確定性轉化為競爭優勢。首先，透過多元化採購管道，選用相容的原料類型，並建立能夠適應關稅和供應波動的條件性採購協議，加強原物料風險管理。其次，在不影響合規性的前提下，透過投資滿足化妝品和藥品應用最高純度要求的純化和分析能力，擴大潛在需求。

我們採用嚴謹的混合方法研究途徑，結合專家訪談、技術檢驗、供應鏈分析和法規分析，為我們的商業性建議奠定基礎。

本調查方法融合了深度訪談、針對性技術檢驗和全面的二手資訊分析，以建立堅實的證據基礎。深度研究包括對來自終端用戶領域的高級採購、配方和法規專業人員進行結構化訪談，以了解他們的決策標準、資格認證經驗以及對政策變化的採購應對措施。此外，還透過與分析化學家和製程工程師的技術交流，對這些定性資料進行三角驗證，以檢驗雜質譜、純化限制和放大生產方面的考量。

簡潔扼要的結論將技術、商業性和監管要求整合為跨部門的必要條件，以實現生物基異Isododecane的成功應用。

本研究的整體結果表明，生物基異Isododecane正從一種小眾替代品轉變為一種重要的基礎原料，這需要嚴格的技術合格、穩健的供應策略以及透明的永續性聲明。採用者必須權衡產品性能與採購實際情況，尤其是在關稅制度和原料供應情況為到岸成本和供應連續性計算引入新變數的情況下。對於配方團隊而言，關鍵問題仍然是感官相容性、雜質控制和法規可追溯性。對於採購和供應鏈經理而言，管理關稅風險、物流複雜性和原料季節性波動仍是首要任務。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章生物來源Isododecane市場（按原始類型分類）

  • 玉米
  • 棕櫚
  • 甘蔗

第9章生物來源Isododecane市場（依純度等級分類）

  • 化妝品級
  • 工業級
  • 醫藥級

第10章生物來源Isododecane市場（依應用領域分類）

  • 化妝品
    • 基礎
    • 口紅
    • 保濕霜
  • 工業溶劑
    • 打掃
    • 塗層
  • 潤滑油
    • 生物潤滑劑
    • 金屬加工油
  • 製藥
    • 吸入溶劑
    • 外用溶劑

第11章生物來源Isododecane市場（以最終用戶分類）

  • 工業的
  • 個人護理
  • 製藥

第12章生物來源Isododecane市場（依銷售管道分類）

  • 直銷
  • 批發商
  • 線上

第13章生物來源Isododecane市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章生物來源Isododecane市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國生物來源Isododecane市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國生物來源Isododecane市場

第17章 中國生物來源Isododecane市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arkema SA
  • BASF SE
  • Clariant AG
  • Croda International Plc
  • Dow Inc.
  • Evonik Industries AG
  • Haltermann Carless
  • Inolex Chemical Company
  • Koster Keunen, Inc.
  • Solvay SA
  • Symrise AG
Product Code: MRR-92740D85EF14

The Bio-based Isododecane Market was valued at USD 175.29 million in 2025 and is projected to grow to USD 210.72 million in 2026, with a CAGR of 22.38%, reaching USD 721.04 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 175.29 million
Estimated Year [2026] USD 210.72 million
Forecast Year [2032] USD 721.04 million
CAGR (%) 22.38%

A strategic introduction that connects bio-based isododecane's physicochemical advantages to formulation priorities, supply considerations, and regulatory sensitivities

Bio-based isododecane has emerged as a versatile, low-odor, and fast-evaporating hydrocarbon alternative prized across formulation-centric industries. As formulation chemists and procurement teams seek feedstock resilience and improved sustainability credentials, bio-based isododecane is increasingly evaluated for its compatibility with sensitive cosmetic matrices, solvent systems for inhalation products, lubricant backbones, and industrial cleaning formulations. Its physicochemical properties make it attractive where volatility control, skin feel, and solvent purity are critical.

This section frames the product's relevance by connecting material attributes to end-user priorities. For cosmetic formulators, sensory performance and regulatory acceptability dominate decisions, while industrial purchasers emphasize supply continuity and cost-of-goods dynamics. In the pharmaceutical arena, solvent purity and regulatory traceability are paramount. Across these contexts, bio-based feedstocks introduce additional considerations around lifecycle impacts, trace impurities, and certification pathways. The introduction establishes the scope of inquiry by linking technical characteristics to commercial decision drivers, setting the stage for a deeper look at market shifts, segmentation nuances, regional dynamics, and actionable guidance for stakeholders.

Transformative industry dynamics driven by feedstock innovation, certification demands, and purification breakthroughs reshaping adoption pathways for bio-based isododecane

The landscape for bio-based isododecane is undergoing structural shifts driven by sustainability imperatives, technological maturation in fermentation and catalytic pathways, and changes in feedstock availability. Innovation in renewable feedstock processing is gradually improving impurity profiles and reproducibility, enabling wider acceptance in sensitive applications. At the same time, buyers are placing greater emphasis on transparency and third-party certification to substantiate sustainability claims, which reshapes supplier selection criteria and contractual terms.

Concurrently, advancements in downstream purification and analytical methods have reduced barriers to entry for pharmaceutical and high-purity cosmetic applications that previously relied on petrochemical analogues. These technological improvements have been accompanied by evolving procurement strategies: formulators are diversifying supplier bases, integrating longer-term offtake agreements, and structuring quality agreements to mitigate variability. Regulatory scrutiny around bio-based claims and feedstock sourcing is increasing, prompting manufacturers to formalize chain-of-custody documentation and lifecycle accounting. Taken together, these shifts are transitioning the market from early-adopter experimentation toward a more institutionalized procurement and qualification framework.

Comprehensive analysis of how 2025 United States tariff adjustments have reshaped sourcing strategies, supply chain architecture, and customs risk management practices

The tariff environment instituted in 2025 has introduced new layers of complexity for supply chains that cross the United States border, affecting sourcing decisions and contractual risk allocation. Tariff adjustments have influenced landed cost calculations, prompting procurement teams to reassess supplier geographies, freight strategies, and inventory policies. In response, some buyers have shifted to regional sourcing to minimize exposure to cross-border tariff volatility, while others have renegotiated supply agreements to include tariff-sharing clauses or flexible pricing mechanisms tied to customs duties.

Tariff effects have also accelerated attention on local content and domestic production capabilities, incentivizing investments in regional feedstock processing and downstream purification facilities. These investments aim to reduce dependency on long-haul imports and to provide greater control over quality and compliance. Meanwhile, logistics planners have responded by redesigning inventory buffers and by exploring bonded warehousing solutions to manage duty timing. From a regulatory standpoint, tariff changes have increased the value of precise HS code classification and customs expertise, as misclassification risks can lead to unexpected financial exposure. Overall, the cumulative tariff impact has elevated strategic sourcing and customs management to boardroom-level considerations for organizations that rely on bio-based isododecane.

In-depth segmentation insight revealing how application-specific requirements, purity distinctions, end-user priorities, channel dynamics, and feedstock choices dictate qualification and procurement

Segmentation analysis reveals distinct demand drivers and qualification pathways across application, purity grade, end user, sales channel, and feedstock type. Based on Application, the material's value proposition differs markedly: in Cosmetics it functions as a sensory enhancer across Foundation, Lipstick, and Moisturizer formulations where skin feel and rapid drydown are critical; in Industrial Solvents it supports Cleaning and Coatings with solvency profiles that favor rapid evaporation and low residue; in Lubricants it serves as a bio-derived base for Bio-Lubricants and specialized Metalworking Fluids where thermal stability and film properties matter; and in Pharmaceuticals it acts as an Inhalation Solvent and Topical Solvent where solvent purity and compatibility with active ingredients are non-negotiable.

Based on Purity Grade, qualification pathways diverge considerably: Cosmetic Grade materials require sensory and dermatological acceptability evidence, Industrial Grade emphasizes process consistency and impurity tolerance, and Pharmaceutical Grade demands rigorous analytical traceability and compliance with pharmacopeial or regulatory requirements. Based on End User, the purchasing lens shifts from industrial buyers focused on operational uptime and cost-per-liter to personal care formulators prioritizing regulatory alignment and sensory differentiation and to pharma customers focused on validated supply chains and controlled impurity profiles. Based on Sales Channel, procurement behaviors vary between Direct relationships that enable technical collaboration, Distributor arrangements that offer logistical reach and inventory buffering, and Online channels that cater to smaller-volume or rapid-prototyping purchases. Based on Feedstock Type, supply risk and sustainability narratives differ across Corn, Palm, and Sugarcane, each bringing distinct land-use implications, supply seasonality, and certification pathways. Understanding the interplay among these segmentation axes is essential for positioning product specifications, packaging offers, and commercial terms to meet the nuanced expectations of each buyer cohort.

Regional dynamics and production footprints shaping supply resilience, certification priorities, and logistics optimization across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Geographic dynamics for bio-based isododecane reflect regional feedstock availability, regulatory frameworks, and manufacturing footprint considerations. In the Americas, proximity to corn and sugar-derived feedstocks supports localized production and shorter supply chains, with buyers emphasizing traceability and domestic sourcing as priorities. Meanwhile, in Europe, Middle East & Africa, regulatory scrutiny and sustainability reporting requirements create a premium on certified feedstock sourcing and lifecycle transparency, and manufacturers often invest in advanced purification to meet stringent cosmetic and pharmaceutical standards.

In the Asia-Pacific region, diverse feedstock ecosystems and a broad manufacturing base support a wide array of production pathways, from palm-based processes to sugarcane-derived routes. Regional logistics hubs in this geography facilitate exports to adjacent markets, but stakeholders must navigate a patchwork of local regulations and certification regimes. Across all regions, cross-border trade patterns are influenced by feedstock seasonality, currency volatility, and evolving environmental policy. Strategic regional approaches therefore combine local production where feasible with flexible logistics and quality assurance frameworks to ensure consistent product performance and compliance for global customers.

Key competitive and capability insights highlighting how technical differentiation, feedstock integration, and value-added services determine supplier positioning and customer choice

Competitive dynamics in bio-based isododecane center on technical differentiation, feedstock integration, vertical coordination, and value-added services. Leading producers typically combine feedstock sourcing partnerships with downstream purification capabilities and robust quality management systems to meet the demands of high-purity applications. New entrants and specialty chemical firms often compete by offering flexible contract sizes, rapid prototyping support for formulators, or novel feedstock claims backed by third-party validation.

Service providers and toll manufacturers play a critical role in enabling scale-up and in mitigating capital intensity for companies seeking to enter the space. Technical service offerings-such as application trials, analytical method development, and co-development programs-broaden commercial appeal and reduce qualification friction for buyers. Strategic collaborations between suppliers and end users are increasingly common, with joint development agreements used to accelerate product compatibility testing and to secure offtake commitments. Ultimately, the competitive landscape rewards organizations that can marry technical excellence with supply assurance and transparent sustainability narratives.

Actionable strategic recommendations to secure supply resilience, enhance purity capabilities, and align commercial models with sustainability and regulatory requirements

Industry leaders should prioritize a set of pragmatic actions to convert uncertainty into competitive advantage. First, strengthen feedstock risk management by diversifying procurement across compatible feedstock types and by establishing conditional sourcing agreements that can be activated in response to tariff or supply volatility. Second, invest in purification and analytical capacity to meet the highest purity expectations for cosmetic and pharmaceutical applications, thereby expanding addressable demand without compromising compliance.

Third, formalize sustainability and chain-of-custody reporting to support customer claims and to facilitate participation in major corporate procurement programs. Fourth, develop flexible commercial structures such as tiered pricing or shared-tariff mechanisms to mitigate the impact of trade policy shifts for key customers. Fifth, expand technical support offerings, including in-application testing and co-development partnerships, to reduce buyer qualification lead times. Finally, pursue regional manufacturing or tolling partnerships where logistics and tariff exposure materially affect supply cost and reliability. By sequencing these initiatives-prioritizing quality and regulatory readiness while progressively de-risking feedstock and trade exposures-industry leaders can position themselves to capture emerging demand driven by sustainability and formulation innovation.

Rigorous mixed-methods research approach combining expert interviews, technical validation, supply chain mapping, and regulatory analysis to underpin commercial recommendations

The research methodology blends primary interviews, targeted technical validation, and comprehensive secondary intelligence to create a robust evidence base. Primary research included structured interviews with senior procurement, formulation, and regulatory professionals across end-user segments to capture decision criteria, qualification experiences, and procurement responses to policy shifts. These qualitative inputs were triangulated with technical conversations involving analytical chemists and process engineers to validate impurity profiles, purification constraints, and scale-up considerations.

Secondary research encompassed review of regulatory guidance, certification frameworks, and publicly available technical literature on bio-based hydrocarbon production pathways. Supply chain mapping integrated customs data, logistics patterns, and feedstock seasonality to construct plausible sourcing scenarios, while scenario planning exercises were used to stress-test sourcing strategies against tariff and feedstock disruption cases. Throughout the study, findings were validated through iterative peer review and by reconciling technical laboratory summaries with buyer expectations to ensure that commercial recommendations are grounded in practical qualification realities.

A concise conclusion that synthesizes technical, commercial, and regulatory imperatives into a cross-functional imperative for reliable adoption of bio-based isododecane

The cumulative narrative of this study emphasizes that bio-based isododecane is shifting from a niche alternative toward a component that requires disciplined technical qualification, robust supply strategies, and transparent sustainability claims. Adopters must balance product performance against procurement realities, particularly as tariff regimes and feedstock availability inject new variables into landed cost and supply continuity calculations. For formulation teams, the chief concerns remain sensory compatibility, impurity control, and regulatory traceability; for procurement and supply chain leaders, managing tariff exposure, logistics complexity, and feedstock seasonality is paramount.

Success in this environment depends on aligning technical capabilities with commercial flexibility. Organizations that invest in purification and analytical capacity, formalize certification and chain-of-custody practices, and adopt creative contractual mechanisms to share trade policy risk will be better positioned to deliver consistent product performance to their customers. The conclusion synthesizes these themes into a straightforward imperative: treat bio-based isododecane qualification as a cross-functional initiative that bridges R&D, procurement, and regulatory affairs to convert material attributes into reliable commercial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-based Isododecane Market, by Feedstock Type

  • 8.1. Corn
  • 8.2. Palm
  • 8.3. Sugarcane

9. Bio-based Isododecane Market, by Purity Grade

  • 9.1. Cosmetic Grade
  • 9.2. Industrial Grade
  • 9.3. Pharmaceutical Grade

10. Bio-based Isododecane Market, by Application

  • 10.1. Cosmetics
    • 10.1.1. Foundation
    • 10.1.2. Lipstick
    • 10.1.3. Moisturizer
  • 10.2. Industrial Solvents
    • 10.2.1. Cleaning
    • 10.2.2. Coatings
  • 10.3. Lubricants
    • 10.3.1. Bio-Lubricants
    • 10.3.2. Metalworking Fluids
  • 10.4. Pharmaceuticals
    • 10.4.1. Inhalation Solvents
    • 10.4.2. Topical Solvents

11. Bio-based Isododecane Market, by End User

  • 11.1. Industrial
  • 11.2. Personal Care
  • 11.3. Pharma

12. Bio-based Isododecane Market, by Sales Channel

  • 12.1. Direct
  • 12.2. Distributor
  • 12.3. Online

13. Bio-based Isododecane Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bio-based Isododecane Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bio-based Isododecane Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bio-based Isododecane Market

17. China Bio-based Isododecane Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arkema S.A.
  • 18.6. BASF SE
  • 18.7. Clariant AG
  • 18.8. Croda International Plc
  • 18.9. Dow Inc.
  • 18.10. Evonik Industries AG
  • 18.11. Haltermann Carless
  • 18.12. Inolex Chemical Company
  • 18.13. Koster Keunen, Inc.
  • 18.14. Solvay S.A.
  • 18.15. Symrise AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-BASED ISODODECANE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIO-BASED ISODODECANE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PALM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SUGARCANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETIC GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY FOUNDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LIPSTICK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY MOISTURIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY BIO-LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY METALWORKING FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INHALATION SOLVENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY TOPICAL SOLVENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 223. NATO BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL BIO-BASED ISODODECANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BIO-BASED ISODODECANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY FEEDSTOCK TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY INDUSTRIAL SOLVENTS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY LUBRICANTS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA BIO-BASED ISODODECANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)